Issue 3-21, 2022

Use of Karmolis® DROPS in Comprehensive Rehabilitation after COVID-19

¹ Maxim S. Filippov, ¹ Gleb M. Lutokhin, ¹ Svetlana A. Morozova, ¹ Pavel B. Novikov, ¹ Alexey M. Shchikota, ¹ Elena A. Turova

¹ Moscow Scientific and Practical Centre of Medical Rehabilitation, Restorative and Sports Medicine, Moscow, Russian Federation

ABSTRACT

Aim. To evaluate the efficacy and safety of the use of KARMOLIS® DROPS in the rehabilitation of patients after COVID-19 infection.Material and methods. The study included and completed observation of 40 medical staff aged 20 to 60 years who had sufferedfrom COVID-19 in a moderate to severe form. The follow-up period was 21 days. The study participants were divided into two groups.The main group (20 people) received KARMOLIS® DROPS. The control group (20 people) treatment was carried out without the use ofKARMOLIS® DROPS. The effectiveness was evaluated according to a set of clinical and functional indicators.Results and discussion. Against the background of taking KARMOLIS® DROPS, reliable positive dynamics of the subjective assessmentof shortness of breath (MRC scale) and the subjective assessment of sleep quality (Vane A.M. scale) were recorded in the main group.Subjective efficacy of the studied KARMOLIS ® DROPS was noted by almost all patients who underwent treatment, which is probablydue to improved sleep and well-being by reducing autonomic reactions.Taking into account the data obtained during the study, KARMOLIS® DROPS can be used in the recovery process after COVID-19 asa component of comprehensive rehabilitation.Conclusion. The safety of using the herbal medicine KARMOLIS® DROPS was confirmed by the absence of adverse events and casesof decompensation of concomitant diseases during the study. Patients’ emotionally positive perception of the drug ensured its highcompliance.

KEYWORDS: acute respiratory infection, COVID-19, postcovid syndrome, respiratory function, psycho-emotional background, shortness of breath, sleep quality, vegetative disorders, phytotherapy, Karmolis

FOR CITATION: Filippov M.S., Lutokhin G.M., Morozova S.A., Novikov P.B., Shchikota A.M., Turova E.A. Use of KARMOLIS® DROPS in Comprehensive Rehabilitation after COVID-19. Bulletin of Rehabilitation Medicine. 2022; 21 (3): 30-35. https://doi.org/10.38025/2078-1962-2022-21-3-30-35

References:

1. Carda S., Invernizzi M., Bavikatte G., Bensmaïl D., Bianchi F., Deltombe T., Draulans N., Esquenazi A., Francisco G.E., Gross R., Jacinto L.J., Moraleda Pérez S., O’Dell M.W., Reebye R., Verduzco-Gutierrez M., Wissel J., Molteni F. The role of physical and rehabilitation medicine in the COVID-19 pandemic: The clinician’s view. Annals of Physical and Rehabilitation Medicine. 2020; 63(6): 554-556. https://doi.org/10.1016/j.rehab.2020.04.001
2. Prevention, diagnosis and treatment of a new coronavirus infection (COVID-19). Ministry of Health of the Russian Federation. Provisional guidelines: Version 10. 08.02.2021. (In Russ.).
3. Razumov A.N., Ponomarenko G.N., Badtieva V.A. Medical rehabilitation of patients with pneumonia associated with the new COVID-19 coronavirus infection. Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury. 2020; 97(3): 5-13. https://doi.org/10.17116/kurort2020970315 (In Russ.).
4. National Institute for Health and Care Excellence, Royal College of General Practitioners, Healthcare Improvement Scotland SIGN. COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence. 2020. Available at: https://www. nice.org.uk/guidance/ng188
5. Vorobyev P.A. Recommendations for the management of patients with COVID-19 coronavirus infection in the acute phase and in the post-coital syndrome in outpatient settings. Problems of Standardisation in Health Care. 2021; (7-8): 3-96. https://doi.org/10.26347/1607-2502202107-08003-096 9In Russ.).
6. State Register of Medicines. Available at: https://zdravmedinform.ru/grls.html (accessed 13.10.21) (In Russ.).
7. Registration certificate of the medicinal product for medical use “KARMOLIS drops” PN 015043/01 of the Ministry of Health and Social Development. 2008. Available at: https://www.rlsnet.ru/tn_index_id_35592.htm (In Russ.).
8. Investigation of antiviral activity of the drug “Karmolis drops” against influenza viruses and other acute respiratory diseases. Report on the Research Institute of Influenza RAMS. 2004: 8 p. Available at: https://carmolis.ru/assets/images/articles/gripp/gripp11.pdf (In Russ.).
9. Marin G.G., Akimkin V.G., Salmina T.A., Suhova V.A. Preventive and pharmacoeconomical effectiveness of the use of medicinal herbal remedies for streptococcal infections in organized military collectives. The Journal of the National Scientific Society of Infectiologists. 2013; (6): 32-8 (In Russ.).
10. Sahu A.K., Amrithanand V.T., Mathew R., Aggarwal P., Nayer J., Bhoi S. COVID-19 in health care workers - A systematic review and meta-analysis. The American Journal of Emergency Medicine. 2020; 38(9): 1727-1731. https://doi.org/10.1016/j.ajem.2020.05.113
11. Makarova M.R., Lyamina N.P., Somov D.A., Turova E.A., Rassulova M.A., Pogonchenkova I.V., Shchikota A.M. Physical rehabilitation for pneumonia associated with COVID-19. Training and teaching aid. Moscow. 2020. (In Russ.).
12. Pogonchenkova I.V., Belevskij A.S., Meshcheryakova N.N., Makarova M.R., Rassulova M.A., Shchikota A.M., Starodubova A.V., Somov D.A., Turova E.A., Kukshina A.A., Kotel’nikova A.V., Livancova E.N., Varaeva Yu.N., Egorova V.V., Brumberg A.A. Medical rehabilitation of patients with community-ac- quired pneumonia associated with a new coronavirus infection (COVID-19). Methodological guidance. Moscow. 2021. (In Russ.).
13. Vejn A.M. Sleep medicine. Selected lectures on neurology. Moscow. Eidos Media. 2006: 624 p. (In Russ.).

The content is available under the Creative Commons Attribution 4.0 License.

©

This is an open article under the CC BY 4.0 license. Published by the National Medical Research Center for Rehabilitation and Balneology.